Good evening :)
Yatharth Hospital & Trauma Care Services Ltd

Yatharth Hospital & Trauma Care Services Ltd

YATHARTH Share Price

NSE
1,139.505.80% (+62.50)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹10,979 cr, stock is ranked 577

Stock is 2.91x as volatile as Nifty

YATHARTH Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Bad

The stock is overpriced and in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹10,979 cr, stock is ranked 577

Stock is 2.91x as volatile as Nifty

YATHARTH Performance & Key Metrics

YATHARTH Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
60.616.71
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
47.165.920.48%

YATHARTH Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 4 analysts

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

YATHARTH Company Profile

Yatharth Hospital & Trauma Care Services Limited delivers comprehensive super specialty healthcare, spanning cardiology, neurology, oncology, and more.

Investor Presentation

View older View older 

Aug 11, 2026

PDF
View Older Presentations

YATHARTH Similar Stocks (Peers)

Compare with peers Compare with peers 

YATHARTH Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
66.23
66.23
1Y Return
13.94%
13.94%
Buy Reco %
86.67
86.67
PE Ratio
70.80
70.80
1Y Return
10.58%
10.58%
Buy Reco %
83.33
83.33
PE Ratio
108.93
108.93
1Y Return
10.80%
10.80%
Buy Reco %
62.50
62.50
PE Ratio
64.21
64.21
1Y Return
8.51%
8.51%
Buy Reco %
90.00
90.00
PE Ratio
169.57
169.57
1Y Return
22.99%
22.99%
Buy Reco %
90.91
90.91
Compare with Peers

YATHARTH Sentiment Analysis

YATHARTH Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

YATHARTH Stock Summary · August 2026

Management described a strong start to FY27, with the company posting its highest-ever quarterly revenue and profits as revenue rose 51% year on year and EBITDA increased 39%. The call emphasised that this performance was driven by operating leverage, a richer case mix and the early contribution of newer hospitals, which together helped lift occupancy to about 75% and push premium NCR hospitals above INR50,000 ARPOB for the first time. Management also highlighted progress in specialty-led care, especially oncology, and said the expansion into tertiary and quaternary services is improving revenue quality. At the same time, they noted that the newest facilities are still ramping, with Faridabad Sector 20 at EBITDA breakeven within nine months and Agra already above 20% margins, supporting a blended margin profile that reached 23.3%. The network has grown to 2,555 beds, and management reiterated a path toward 5,000 beds over the coming years, with the 250-bed Gurugram facility and additional brownfield beds expected to come onstream next fiscal. They said FY27 execution remains on track, while capex, debt and depreciation will remain elevated near term.

YATHARTH Stock Growth Drivers
YATHARTH Stock Growth Drivers
9
  • Record Operating Performance and Early FY27 Momentum

    The company delivered a very strong start to FY27, with quarterly revenue and profits reaching

  • Successful Ramp-Up of New Hospitals and Acquisition-Led Expansion

    Newer hospitals in Greater Faridabad, New Delhi Faridabad Sector 20, Agra, and related assets are

YATHARTH Stock Challenges
YATHARTH Stock Challenges
3
  • Underperforming New Hospital Ramp-Up and EBITDA Drag

    Recent hospital additions are still weighing on profitability, with certain facilities not yet operating at

  • Weak Government Business Momentum Despite Revenue Mix Improvement

    The increase in government payer contribution to about 40% of revenue does not reflect stronger

YATHARTH Forecast

YATHARTH Forecasts

Price

Revenue

Earnings

YATHARTH

YATHARTH

Income

Balance Sheet

Cash Flow

YATHARTH Income Statement

YATHARTH Income Statement

Loading...

Quartermar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025mar 2026jun 2026
Total Revenue183.41215.44220.74223.37237.12267.08288.91328.30348.67397.01
Operating & Other expensessubtract131.22158.12163.14164.24174.75193.28214.90246.22261.65300.97
Depreciation/Amortizationsubtract7.7011.4415.9516.9112.8714.9218.9323.9630.0028.24
Interest & Other Itemssubtract0.382.921.562.060.970.190.261.025.076.59
Taxes & Other Itemssubtract5.7612.579.149.679.8216.6513.5911.744.4414.15
EPS4.853.543.593.574.374.364.284.714.934.88

YATHARTH Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2027FY 2027

Annual Report Pending

Investor Presentation

Aug 11PDF
Aug 10PDF
FY 2026FY 2026

Annual report

PDF

Investor Presentation

May 25PDF
Feb 5PDF
Nov 13PDF
Aug 5PDF
FY 2025FY 2025

Annual report

PDF

Investor Presentation

Jan 27PDF
Nov 26PDF
Nov 7PDF
FY 2024FY 2024

Annual report

PDF

Investor Presentation

Aug 18PDF
FY 2023FY 2023

Annual report

PDF
 

YATHARTH Stock Peers

YATHARTH Past Performance & Peer Comparison

YATHARTH Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Yatharth Hospital & Trauma Care Services Ltd62.616.71
Apollo Hospitals Enterprise Limited66.2312.890.22%
Max Healthcare Institute Limited70.809.500.19%
Manipal Health Enterprises Limited108.9311.05

YATHARTH Stock Price Comparison

Compare YATHARTH with any stock or ETF
Compare YATHARTH with any stock or ETF
YATHARTH
Loading...

YATHARTH Holdings

YATHARTH Shareholdings

YATHARTH Promoter Holdings Trend

YATHARTH Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

YATHARTH Institutional Holdings Trend

YATHARTH Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

YATHARTH Shareholding Pattern

YATHARTH Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding55.80%9.74%1.10%5.62%27.74%

Sep 2025

Dec 2025

Mar 2026

Jun 2026

YATHARTH Shareholding History

YATHARTH Shareholding History

MarJunSepDec '25MarJun4.45%4.34%6.50%6.18%5.25%5.62%

Mutual Funds Invested in YATHARTH

Mutual Funds Invested in YATHARTH

No mutual funds holding trends are available

Top 5 Mutual Funds holding Yatharth Hospital & Trauma Care Services Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
3.6499%1.17%-0.06%10/277 (-2)
2.8771%1.03%0.07%55/84 (0)
1.0087%0.64%0.09%129/240 (+1)

Compare 3-month MF holding change on Screener

YATHARTH Insider Trades & Bulk Stock Deals

YATHARTH Insider Trades & Bulk Stock Deals

Loading...

smallcases containing YATHARTH stock

smallcases containing YATHARTH stock

Looks like this stock is not in any smallcase yet.

YATHARTH Events

YATHARTH Events

YATHARTH Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

YATHARTH has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

YATHARTH Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

YATHARTH has not given any dividends in last 5 years

YATHARTH Upcoming Dividends

YATHARTH Upcoming Dividends

No upcoming dividends are available

YATHARTH Past Dividends

YATHARTH Past Dividends

Cash Dividend

Ex DateEx DateAug 14, 2026

Interim 1
Interim 1 | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Aug 14, 2026

YATHARTH Stock News & Opinions

YATHARTH Stock News & Opinions

Corporate
Corporate
Yatharth Hospital secures investment from Rasmalai Limited, gaining a public shareholder

Yatharth Hospital & Trauma Care Services Limited is set to receive a significant investment from Rasmalai Limited through a preferential issue of 1,30,26,516 equity shares and 1,89,47,664 warrants. The deal, finalized September 17, 2026, will result in Rasmalai Limited holding approximately 24.87% of the company’s fully diluted share capital and becoming a public, non-promoter shareholder. As part of the agreement, Rasmalai Limited will have the right to nominate directors to the board and key committees, alongside existing promoter rights. The promoters, including Dr. Ajay Kumar Tyagi, Dr. Kapil Kumar, Dr. Neena Tyagi, and Dr. Manju Tyagi, are subject to a three-year lock-in period and could potentially transfer shares to Dr. Tyagi if Rasmalai Limited achieves a three-times return on its investment. The transaction remains contingent on approvals from regulatory bodies including the BSE Limited and National Stock Exchange of India Limited.

2 days agoCapital Market - Live
Corporate
Corporate
Yatharth Hospital secures INR 31.5 billion investment from Cyprus-based Rasmalai Limited

Yatharth Hospital & Trauma Care Services Limited has entered into an agreement with Rasmalai Limited, a Cyprus-based investor, for a preferential issue of securities valued at approximately INR 31.5 billion. The transaction will grant Rasmalai Limited a 24.87% stake in the company on a fully diluted basis. As part of the agreement, Rasmalai Limited will have the right to nominate directors to the board and approve certain key decisions, contingent on shareholding thresholds. Existing promoters, including Dr. Ajay Kumar Tyagi, Dr. Kapil Kumar, Dr. Neena Tyagi, and Dr. Manju Tyagi, will also retain certain rights and are subject to a three-year lock-in period on their shares. The deal, finalized September 17, 2026, requires regulatory approvals from the BSE Limited, National Stock Exchange of India Limited, and the Competition Commission of India and does not constitute a change in control of the company.

2 days agoCapital Market - Live
Corporate
Corporate
Yatharth Hospital plans to consider fundraising options, including equity, at a board meeting

Yatharth Hospital & Trauma Care Services Limited will hold a board meeting on Thursday, September 17, 2026, to discuss growth plans and consider raising funds through debt, a rights issue, preferential allotment, qualified institutions placement, or other permissible modes, potentially including equity shares, warrants, debt securities, or other eligible securities.

5 days agoCapital Market - Live
Corporate
Corporate
Yatharth Hospital denies disclosure needed after report of potential stake acquisition

Yatharth Hospital & Trauma Care Services Limited confirmed on August 28, 2026, that there is no information requiring disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, in response to a news report that Aster and Advent are considering a controlling stake in Yatharth Hospital, which caused the company’s shares to rise 4.5%.

3 weeks agoCapital Market - Live
Corporate
Corporate
Yatharth Hospital to hold annual meeting via video conference on September 25, 2026

Yatharth Hospital & Trauma Care Services Limited will hold its 19th Annual General Meeting on Friday, September 25, 2026, at 12:00 Noon (IST) through Video Conferencing/ Other Audio-Visual Means, as announced to the National Stock Exchange of India Limited and BSE Limited on August 21, 2026.

4 weeks agoCapital Market - Live
Earnings
Earnings
Yatharth Hospital & Trauma Care Services Ltd consolidated sales up 14.96% on year in Q2FY2026

Yatharth Hospital & Trauma Care Services Ltd share price declined by 0.06% to Rs 870.25. The Company's net profit saw a marginal increase of 1.61% to Rs 45.42 crore, while revenue from operations increased 14.96% to Rs 392.65 crore in Q2FY26 over Q1FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 5.1 lakh crore, rising 5.23%. It has significantly gained 16.82% over last one week and rallied by 33.82% in last one month while the market capitalization of Yatharth Hospital & Trauma Care Services Ltd has inched up 4.32% and 6.35% in the same period respectively. Profit before tax (PBT) of Yatharth Hospital & Trauma Care Services Ltd stood at Rs 61.21 crore in Q2 FY26, gaining 4.29% year-on-year, and expanding by 17.82% quarter-on-quarter. EBITDA came in at Rs 87 crore, rallying 58.26% YoY and surging by 19.94% sequentially. Total expenses increased by 12.88% to Rs 329.21 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 71.1 crore, witnessing a sharp rise of 22.95% YoY, while employee benefits expense was at Rs 77.91 crore, rising by 11.14% YoY. For the TTM ended FY26, revenue from operations witnessed a strong growth of 31.31% to Rs 880.49 crore, while net profit registered a growth of 14.04% to Rs 130.55 crore, compared to previous TTM. EBITDA surged by 19114% to Rs 204.01 crore, and PBT saw a minor gain of 9.51% to Rs 171.74 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 131.17 crore in FY26, as against Rs 3.08 crore in FY25. Yatharth Hospital & Trauma Care Services Ltd soared by 25.86% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 2.63% during the same period.

1 month agoCapital Market - Live
Corporate
Corporate
Yatharth Hospital sets August 14 as record date for interim dividend of Rs 0.50 per share

Yatharth Hospital & Trauma Care Services Limited has fixed August 14, 2026, as the record date for determining entitlement to a First Interim Dividend of Rs 0.50 per equity share, representing 5% of the face value of Rs 10 each, during the financial year 2026-27.

1 month agoCapital Market - Live
Corporate
Corporate
Yatharth Hospital’s board will meet August 10 to review financials and consider a dividend

Yatharth Hospital & Trauma Care Services Limited will hold a board meeting on August 10, 2026, to consider and approve the unaudited financial results for the first quarter ended June 30, 2026, declare a first interim dividend for the financial year 2026-27, and approve the “Yatharth Hospital & Trauma Care Services Employees Stock Option Scheme-2026” for the company and its subsidiaries.

1 month agoCapital Market - Live
Spotlight
Spotlight
Yatharth Hospitals gains after Q4 PAT climbs 23% YoY to Rs 47 cr

EBITDA stood at Rs 79.9 crore, up 37% as compared with Rs 58.3 crore recorded in the same quarter last year. EBITDA margin reduced by 161 bps to 23.4% in Q4 FY26 as against 25% in Q4 FY25. During the quarter, Group ARPOB increased 5% YoY to Rs 33,283, driven by a higher contribution from high-value specialties and strong traction across newer hospitals. Yatharth Tyagi, whole-time director, Yatharth Hospital and Trauma Care Services, said, 'We are pleased to report a strong close to FY26, with Q4 delivering an industry-leading performance. The quarter and indeed the full year reflect our capabilities in not only acquiring newer hospitals but also in integrating, scaling, and turning these assets into profitability. Our newer hospitals at Model Town (New Delhi), Faridabad Sector-20, and Agra have demonstrated a rapid scale-up, contributing meaningfully to the Group's revenues within a short span of operations. The successful integration of the Agra facility has further strengthened our regional presence, while the Group's entry into Gurugram with a 250-bed ultra-modern, high-end hospital enhances our positioning within the NCR market.' Yatharth Hospital & Trauma Care Services (Yatharth Hospitals) is a North India-based healthcare provider operating a network of super-specialty hospitals across Noida, Greater Noida, Noida Extension, Greater Faridabad, New Delhi, Gurugram, and Jhansi-Orchha, with a growing presence in Agra. The company has over 2,500 beds across its hospital network and offers healthcare services across multiple specialties and super-specialties.Powered by Capital Market - Live

3 months agoCapital Market - Live
Spotlight
Spotlight
Yatharth Hospitals Q4 PAT climbs 23% YoY to Rs 47 cr

EBITDA stood at Rs 79.9 crore, up 37% as compared with Rs 58.3 crore recorded in the same quarter last year. EBITDA margin reduced by 161 bps to 23.4% in Q4 FY26 as against 25% in Q4 FY25. During the quarter, Group ARPOB increased 5% YoY to Rs 33,283, driven by a higher contribution from high-value specialties and strong traction across newer hospitals. Yatharth Tyagi, whole time director, Yatharth Hospital and Trauma Care Services, said, 'We are pleased to report a strong close to FY26, with Q4 delivering an industry-leading performance. The quarter and indeed the full year reflects our capabilities in not only acquiring newer hospitals, but also in integrating, scaling, and turning these assets into profitability. Our newer hospitals at Model Town (New Delhi), Faridabad Sector-20, and Agra have demonstrated a rapid scale-up, contributing meaningfully to the Group's revenues within a short span of operations. The successful integration of the Agra facility has further strengthened our regional presence, while the Group's entry into Gurugram with a 250-bed ultra-modern, high-end hospital enhances our positioning within the NCR market.' Yatharth Hospital & Trauma Care Services (Yatharth Hospitals) is a North India-based healthcare provider operating a network of super-specialty hospitals across Noida, Greater Noida, Noida Extension, Greater Faridabad, New Delhi, Gurugram, and Jhansi-Orchha, with a growing presence in Agra. The company has over 2,500 beds across its hospital network and offers healthcare services across multiple specialties and super-specialties. Shares of Yatharth Hospital and Trauma Care Services fell 4.51% to Rs 824 on the BSE.Powered by Capital Market - Live

3 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. The share price of YATHARTH as on 18th September 2026 is ₹1139.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. The past returns of Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) share are
    • Past 1 week: 17.62%
    • Past 1 month: 34.50%
    • Past 3 months: 34.83%
    • Past 6 months: 69.24%
    • Past 1 year: 44.38%
    • Past 3 years: 200.34%
    • Past 5 years: 241.32%

  3. Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) is ₹10979.58 Cr as of 18th September 2026.

  4. The 52-week high of Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) is ₹1184 and the 52-week low is ₹538.25.

  5. The P/E (price-to-earnings) ratio of Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) is 62.61. The P/B (price-to-book) ratio is 6.71.

  6. Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.

  7. You can directly buy Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) shares on Tickertape. Simply sign up, connect your demat account and place your order.